These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26136510)

  • 21. Relevant associations of the glucokinase regulatory protein/glucokinase gene variation with TAG concentrations in a high-cardiovascular risk population: modulation by the Mediterranean diet.
    Sotos-Prieto M; Guillén M; Vicente Sorli J; Portolés O; Guillem-Saiz P; Ignacio Gonzalez J; Qi L; Corella D
    Br J Nutr; 2013 Jan; 109(2):193-201. PubMed ID: 22716779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism.
    Garcia-Rios A; Delgado-Lista J; Perez-Martinez P; Phillips CM; Ferguson JF; Gjelstad IM; Williams CM; Karlström B; Kieć-Wilk B; Blaak EE; Lairon D; Planells R; Malczewska-Malec M; Defoort C; Riserus U; Saris WH; Lovegrove JA; Drevon CA; Roche HM; Lopez-Miranda J
    Atherosclerosis; 2011 Oct; 218(2):416-22. PubMed ID: 21840003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
    Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.
    Tracz A; Madzio J; Gnys P; Malachowska B; Borowiec M; Wyka K; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Mlynarski W; Fendler W;
    Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants.
    Li J; Zhao Y; Zhang H; Hua W; Jiao W; Du X; Rui J; Li S; Teng H; Shi B; Yang X; Zhu L
    Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1696-1708. PubMed ID: 33243135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific impact of
    Sakamoto S; Kakehi S; Abudurezake A; Kaga H; Someya Y; Tabata H; Yoshizawa Y; Naito H; Tajima T; Ito N; Kawamori R; Watada H; Tamura Y
    Ther Adv Endocrinol Metab; 2024; 15():20420188241280540. PubMed ID: 39346030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.
    Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Martínez JA; Moreno-Aliaga MJ
    J Physiol Biochem; 2013 Sep; 69(3):633-51. PubMed ID: 23794360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between a polymorphism in the pleiotropic GCKR and Age-related phenotypes: the HALCyon programme.
    Alfred T; Ben-Shlomo Y; Cooper R; Hardy R; Deary IJ; Elliott J; Harris SE; Kivimaki M; Kumari M; Power C; Starr JM; Kuh D; Day IN;
    PLoS One; 2013; 8(7):e70045. PubMed ID: 23894584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
    Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children.
    Horvatovich K; Bokor S; Polgar N; Kisfali P; Hadarits F; Jaromi L; Csongei V; Repasy J; Molnar D; Melegh B
    Diabetes Metab; 2011 Nov; 37(5):432-9. PubMed ID: 21511510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.
    Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Phillips CM; Hall W; Gjelstad IM; Lairon D; Saris W; Kieć-Wilk B; Karlström B; Drevon CA; Defoort C; Blaak EE; Dembinska-Kieć A; Risérus U; Lovegrove JA; Roche HM; Lopez-Miranda J
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):417-23. PubMed ID: 22269963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes regulating levels of ω-3 long-chain polyunsaturated fatty acids are associated with alcohol use disorder and consumption, and broader externalizing behavior in humans.
    Aliev F; Barr PB; Davies AG; Dick DM; Bettinger JC
    Alcohol Clin Exp Res; 2022 Sep; 46(9):1657-1664. PubMed ID: 35904282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coffee consumption affects kidney function based on GCKR polymorphism in a Korean population.
    Kim MJ; Jin HS; Eom YB
    Nutr Res; 2024 Feb; 122():92-100. PubMed ID: 38215572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial.
    Tremblay BL; Cormier H; Rudkowska I; Lemieux S; Couture P; Vohl MC
    Lipids Health Dis; 2015 Feb; 14():12. PubMed ID: 25889305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    Am J Clin Nutr; 2009 Dec; 90(6):1665-73. PubMed ID: 19828715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of
    Cheung CYY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CHY; Kwok KHM; Chow WS; Woo YC; Yuen MMA; Cherny SS; Hai J; Cheung BMY; Tan KCB; Lam TH; Tse HF; Sham PC; Lam KSL
    Diabetes; 2017 Jun; 66(6):1723-1728. PubMed ID: 28385800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
    Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.
    Rees MG; Ng D; Ruppert S; Turner C; Beer NL; Swift AJ; Morken MA; Below JE; Blech I; ; Mullikin JC; McCarthy MI; Biesecker LG; Gloyn AL; Collins FS
    J Clin Invest; 2012 Jan; 122(1):205-17. PubMed ID: 22182842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal supplementation with n-3 long chain polyunsaturated fatty acids during perinatal period alleviates the metabolic syndrome disturbances in adult hamster pups fed a high-fat diet after weaning.
    Kasbi-Chadli F; Boquien CY; Simard G; Ulmann L; Mimouni V; Leray V; Meynier A; Ferchaud-Roucher V; Champ M; Nguyen P; Ouguerram K
    J Nutr Biochem; 2014 Jul; 25(7):726-33. PubMed ID: 24767307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.